文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Substantial overlap between NAFLD and MASLD with comparable disease severity and non-invasive test performance: An analysis of the Indian Consortium on MASLD (ICOM-D) cohort.

作者信息

De Arka, Mehta Manu, Duseja Ajay

机构信息

Department of Hepatology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

Department of Hepatology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

出版信息

J Hepatol. 2024 Oct;81(4):e162-e164. doi: 10.1016/j.jhep.2024.05.027. Epub 2024 May 25.

DOI:10.1016/j.jhep.2024.05.027
PMID:38801919
Abstract
摘要

相似文献

[1]
Substantial overlap between NAFLD and MASLD with comparable disease severity and non-invasive test performance: An analysis of the Indian Consortium on MASLD (ICOM-D) cohort.

J Hepatol. 2024-10

[2]
[Analysis of non-alcoholic fatty liver disease differences from metabolic dysfunction-associated fatty liver disease based on clinical features].

Zhonghua Gan Zang Bing Za Zhi. 2024-4-20

[3]
Clinicopathological Profile and Outcome of a Large Cohort of Patients with Nonalcoholic Fatty Liver Disease from South Asia: Interim Results of the Indian Consortium on Nonalcoholic Fatty Liver Disease.

Metab Syndr Relat Disord. 2022-4

[4]
Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease.

J Hepatol. 2024-5

[5]
Diagnostic performance of non-invasive liver fibrosis risk scores in biopsy-proven non-alcoholic fatty liver disease patients in India.

Indian J Gastroenterol. 2023-4

[6]
Changing from NAFLD to MASLD: Prevalence and progression of ASCVD risk are similar between NAFLD and MASLD in Asia.

Clin Mol Hepatol. 2024-7

[7]
MASLD identifies patients with significant hepatic fibrosis and steatosis in fatty liver population.

Ann Hepatol. 2024

[8]
FAST and Agile-the MASLD drift: Validation of Agile 3+, Agile 4 and FAST scores in 246 biopsy-proven NAFLD patients meeting MASLD criteria of prevalent caucasian origin.

PLoS One. 2024

[9]
[Diagnosis and evaluation of metabolic dysfunction associated steatotic liver disease (MASLD)].

Rev Med Interne. 2024-1

[10]
Prognostic value of metabolic dysfunction-associated steatotic liver disease over coronary computed tomography angiography findings: comparison with no-alcoholic fatty liver disease.

Cardiovasc Diabetol. 2024-5-10

引用本文的文献

[1]
MISHTI study evaluating hepatic fibrosis in type 2 diabetes patients in India.

Sci Rep. 2025-7-9

[2]
Adoption of the New Nomenclature of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) by the Indian National Association for Study of the Liver (INASL): Implications for the INASL Guidance Paper on NAFLD.

J Clin Exp Hepatol. 2025

[3]
Fibrosis-4 and NAFLD Fibrosis Scores Have Good Specificity to Rule Out Advanced Fibrosis in Healthy Liver Donors: A Biopsy-Based Study.

J Clin Exp Hepatol. 2025

[4]
In Silico Analysis of Saroglitazar and Ferulic Acid Binding to Human Ketohexokinase: Implications for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Cureus. 2025-2-22

[5]
Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes Mellitus: A Review and Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association.

Diabetes Metab J. 2024-11

[6]
Association of depression with severe non-alcoholic fatty liver disease: evidence from the UK Biobank study and Mendelian randomization analysis.

Sci Rep. 2024-11-19

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索